USPTO serial 79336602
IMMULAB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 10, 2023
- Examiner
- SINGH, TEJBIR
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IMMULAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz Venable LLPP.O. Box 34385Washington, DC 20043-9998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biological reagents for non-medical purposes; chemical test kits comprised of chemical preparations for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific and/or industrial purposes; diagnostic and chemical reagents for testing for scientific and research purposes; chemical and biological reagents for non-medical purposes; chemical and biological reagents for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes, all the aforesaid being for scientific and research purposes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for anti-body screening, blood grouping, and the typing and detection of specific blood cells for scientific and research purposes | ACTIVE | — |
| 005 | Pharmaceutical preparations and substances, namely, blood grouping serums and blood typing serums, namely, medical reagents and assays for testing blood to determine blood type; blood components for medical purposes, namely, platelets, plasma and red blood cells; pharmaceutical test kits in this class, being for diagnostic medical purposes, namely, diagnostic test kits comprised of medical diagnostic reagents and assays for clinical laboratory use in use in blood grouping and antibody screening; blood products for medical purposes, namely, blood plasma, reagent blood cells; reagents for medical use, namely, reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; clinical medical reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; pharmaceutical preparations, namely, reagent red blood cells used for quality control in immunohematology tests to detect antibodies or immunoglobulin subtypes; diagnostic reagents for medical or veterinary use; pharmaceutical preparations, namely, reagent red blood cells for medical use and medical testing used to detect antibodies or immunoglobulin subtypes; test kits comprised of medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; biological reagents for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 15, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 17, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 26, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 26, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 10, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 10, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 10, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 25, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 25, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 5, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 19, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 25, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 25, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 29, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 29, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 8, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 25, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 24, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |